Skip to main content Help with accessibility Skip to main navigation

Clinical Guidelines

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - March - 2018

This guidance has been produced to facilitate the safe prescribing of LMWHs in primary care. It provides an overview of points to be considered when initiating LMWHs and when transferring prescribing responsibilities to or from another organisation.

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 03 - December - 2024
BNF chapter: Central nervous system

This is a summary document intended for Primary Care, taken from a more comprehensive document ‘Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) in Primary and Secondary Care. This document should be accessed for additional resources such as the Leaflet for Care Home Staff, assessment forms and flow chart for responding to BPSD.

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 03 - December - 2024
BNF chapter: Central nervous system

Information contained within this document is largely taken from the PrescQIPP toolkit ‘Reducing Antipsychotics in Dementia and documents available on the Alzheimer’s Society website.

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 16 - May - 2024

This guideline comprises a flow chart outlining a stepwise approach to the management of psoriasis in adults and in children and young people. The guideline also includes relevant treatment review periods and referral criteria.

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 19 - November - 2024
BNF chapter: Central nervous system
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 18 - December - 2024
BNF chapter: Central nervous system
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 25 - September - 2023
BNF chapter: Skin
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - November - 2017
BNF chapter: Eye
  • Age related Macular Degeneration   

  • Diabetic Macular Oedema 

  • Macular Oedema secondary to Central Retinal Vein Occlusion

  • Macular Oedema secondary to Branch Retinal Vein Occlusion

  • CNV associated with pathological myopia

  • Vitreomacular Traction

Not adopted
Adopted
Adopted
Not adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - September - 2018
BNF chapter: Blood and Nutrition

The purpose of oral nutritional supplementation (ONS) is to supplement food intake, not replace it and their use does not remove the need to manage the underlying condition responsible for the patient’s poor appetite. It is important to ensure that prescribing is both appropriate for the patient and that the treatment length is such that waste is minimised.

Last updated on LSCMMG January 2023

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - December - 2019

In developing local commissioning policies, the CCG will commission treatments or services which accord with all of the following principles:

  • Appropriateness
  • Effectiveness
  • Cost-effectiveness
  • Ethics
  • Affordability

A number of treatments which should be considered a LOW PRIORITY are detailed within this policy

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Pending
Date Posted: 22 - December - 2023
BNF chapter: Genito-urinary system
Adopted
Adopted
Pending
Adopted
Adopted
Pending
Adopted
Adopted

Guidance on consensus approaches to managing Palliative Care Symptoms

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - November - 2016

The purpose of this guidance is to outline recommendations for prescribing within primary care in Lancashire and South Cumbria. It is intended to provide information on current best practice including providing advice on prescribing situations which are not always clear so as to ensure a consistent approach by primary care prescribers across Lancashire and South Cumbria. All prescribers are encouraged to follow this guide.

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Pending
Date Posted: 19 - July - 2022
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - November - 2018
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 14 - December - 2022
Not adopted
Adopted
Adopted
Not adopted
Adopted
Adopted
Pending
Pending
Date Posted: 09 - April - 2024
BNF chapter: Infection
Adapted from NICE guideline 112
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 22 - November - 2023
BNF chapter: Musculoskeletal system

The purpose of these guidelines is to provide a quick reference guide for use in primary care summarising information on the diagnosis and management of RLS in primary care. This guidance covers the management of RLS in primary care and gives information about when to refer to secondary care. 

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 14 - August - 2019
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - February - 2019
BNF chapter: Central nervous system

The purpose of this guidance is to provide clarity on the approval process for the prescribing of the second-generation antipsychotic long-acting injections within Lancashire Care NHS Foundation Trust.